2 2 9 2 g
Home About us MoEF Contact us Sitemap Tamil Website  
About Envis
Whats New
Microorganisms
Research on Microbes
Database
Bibliography
Publications
Library
E-Resources
Microbiology Experts
Events
Online Submission
Access Statistics

Site Visitors

blog tracking


 
Electronic Journal of Biotechnology
Vol. 28, 2017, Pages: 95-100

Mannheimia haemolytica growth and leukotoxin production for vaccine manufacturing A bioprocess review

TobiasOppermann, NadineBusse, PeterCzermak

Fraunhofer Institute for Molecular Biology and Applied Ecology, Project Group Bioresources, Winchesterstrasse 2, 35394 Giessen, Germany.

Abstract

Mannheimia haemolytica leukotoxin (LKT) is a known cause of bovine respiratory disease (BRD) which results in severe economic losses in the cattle industry (up to USD 1 billion per year in the USA). Vaccines based on LKT offer the most promising measure to contain BRD outbreaks and are already commercially available. However, insufficient LKT yields, predominantly reflecting a lack of knowledge about the LKT expression process, remain a significant engineering problem and further bioprocess optimization is required to increase process efficiency. Most previous investigations have focused on LKT activity and cell growth, but neither of these parameters defines reliable criteria for the improvement of LKT yields. In this article, we review the most important process conditions and operational parameters (temperature, pH, substrate concentration, dissolved oxygen level, medium composition and the presence of metabolites) from a bioprocess engineering perspective, in order to maximize LKT yields.

Keywords: Bovine respiratory disease, Cell growth, Commensal flora of cattle, Enzootic calf pneumonia, Facultatively anaerobic, Gram-negative, Leukotoxin production, Mastitis in sheep, Operational parameters, Mannheimia haemolytica, Rod-shaped bacteria.

 
Copyright © 2005 ENVIS Centre ! All rights reserved
This site is optimized for 1024 x 768 screen resolution